Nightmares and Mirtazapine—Time to be vigilant

Nightmares and Mirtazapine—Time to be vigilant

Bibliographic Details
Main Authors:	Sree Sudha TY, Saritha VenkataNaga, Pugazhenthan Thangaraju
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-09-01
Series:	Indian Journal of Psychological Medicine
Online Access:	https://doi.org/10.1177/0253717620926785

Similar Items

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
by: Pugazhenthan Thangaraju, et al.
Published: (2017-01-01)

Drug flibanserin–in hypoactive sexual desire disorder
by: Pugazhenthan Thangaraju, et al.
Published: (2022-06-01)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
by: Pugazhenthan Thangaraju, et al.
Published: (2023-08-01)

Occurrence of Terrifying Nightmares after Few Days of Mirtazapine Use in Elderly Patients
by: Liliana Dell’Osso, et al.
Published: (2023-01-01)

Need for vigilance monitoring regarding neurological disorders post-COVID vaccination
by: Pugazhenthan Thangaraju, et al.
Published: (2023-08-01)

Vigilance in selection of low-dose versus high-dose steroids in COVID-19
by: Pugazhenthan Thangaraju, et al.
Published: (2021-08-01)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
by: Pugazhenthan Thangaraju, MD, et al.
Published: (2022-11-01)

Paediatric dosage ‘need of hours among family physicians/other speciality physicians’
by: Pugazhenthan Thangaraju, et al.
Published: (2022-01-01)

A review and case report of enigmatic superficial endometrial spread of cancer of the uterine cervix: Need for vigilance in the primary care setting
by: Madhuri N Bagde, et al.
Published: (2021-01-01)

Hydroxyprogesterone caproate for preterm birth: A situational analysis from the Indian perspective
by: Pugazhenthan Thangaraju, et al.
Published: (2021-09-01)

Myoclonus Associated with Mirtazapine
by: Surabhi Sharma, et al.
Published: (2024-07-01)

Papilledema Due to Mirtazapine
by: Mehmet Emin Ceylan, et al.
Published: (2016-06-01)

Estimation of Prevalence and Comparing the Levels of Stress, Anxiety, Depression, and Psychological Impact Before and After COVID-19 Lockdown Among Front Line Health Care Workers
by: Sri Lakshmi Latha MBBS, MD, et al.
Published: (2022-01-01)

The Use Of Mirtazapine As A Hypnotic
by: Francisca Magalhães Scoralick, et al.
Published: (2024-11-01)

Mirtazapine-Induced Thrombocytopenia and Neutropenia
by: Selami K Toprak, et al.
Published: (2012-08-01)

Usefulness of mirtazapine in cancer patients
by: Massimo Pasquini, et al.
Published: (2010-09-01)

Mirtazapine for the Treatment of Chronic Pruritus
by: Raveena Khanna, et al.
Published: (2019-07-01)

Violence against doctor – few points to be focussed
by: Pugazhenthan Thangaraju
Published: (2020-01-01)

Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study
by: T Y Sree Sudha, et al.
Published: (2022-01-01)

Nightmare
by: Tan, Yan Yun
Published: (2022)

Early effects of mirtazapine on emotional processing.
by: Arnone, D, et al.
Published: (2009)

Effects of mirtazapine on cisplatin cardiotoxicity in rats
by: Onural Ozhan, et al.
Published: (2023-06-01)

Mirtazapine for symptom control in refractory gastroparesis
by: Malamood M, et al.
Published: (2017-03-01)

Mirtazapine-induced acute angle closure
by: Nilay Kahraman, et al.
Published: (2015-01-01)

Synthesis of potential related substances of mirtazapine
by: Divvela V. N. Srinivasa Rao, et al.
Published: (2006-12-01)

The overdiagnosis nightmare: a time for caution
by: Ciatto Stefano
Published: (2009-12-01)

A study of risk factors and complications in elderly hypertensive subjects
by: T Y Sri Hari, et al.
Published: (2021-01-01)

Mirtazapine versus other antidepressive agents for depression.
by: Watanabe, N, et al.
Published: (2011)

Mirtazapine versus fluoxetine in the treatment of panic disorder
by: L. Ribeiro, et al.
Published: (2001-10-01)

The role of mirtazapine in the management of psychosis in Parkinson’s disease
by: N Uvais
Published: (2020-01-01)

Mirtazapine induced tremors: A case report
by: N A Uvais, et al.
Published: (2019-01-01)

The Brazilian Nightmare
by: Alfredo Gugliano, et al.
Published: (2022-09-01)

Girl of nightmares /
by: 548885 Blake, Kendare
Published: (2012)

The nightmare room /
by: Stine, R. L., author
Published: (2005)

Differential onset time of mirtazapine on pruritus and depression in a patient receiving hemodialysis
by: Yu Miyahara, et al.
Published: (2021-01-01)

Nightmare frequency and nightmare distress: Socio-demographic and personality factors
by: Michael Schred, et al.
Published: (2019-09-01)

Dünya Sağlık Örgütünün 2019'da küresel sağlığa tehdit ettiğini belirttiği on tehditten biri: Antimikrobiyal direnç
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-09-01)

DSÖ lepra tedavi kılavuzu: farmakovijilansa odaklanma
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-06-01)

Cüzzamın yeniden alevlenmesine yönelik mücadele stratejileri: Vurgulanması gereken noktalar
by: Sajitha VENKATESAN, et al.
Published: (2019-12-01)

Monotherapy with liraglutide – Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)